Financial Statement 13/14
September 2013 – August 2014, Diamyd Medical AB (publ), Fiscal year 2013/2014Reporting period, June 1, 2014 – August 31, 2014 · Net sales amounted to MSEK 0.2 (0,1) · Loss before tax amounted to MSEK -3.3 (-4.3) · Liquid assets and short term investments amounted to MSEK 35.7 (65.5) as of August 31, 2014 Full year, September 1, 2013 – August 31, 2014 · Net sales amounted to MSEK 0.4 (0.1) · Loss before tax amounted to MSEK -16.0 (-12.6) Significant events during the reporting period · Clinical study with Diamyd Medical’s diabetes vaccine fully recruited ·
